Northbound Therapeutics Inc is a Research and Development Laboratories business in Oklahoma City, OK.
| Business Name: | Northbound Therapeutics Inc |
| Categorized In: | Research and Development Laboratories |
| Address: | 940 Sl Young Boulevard, Oklahoma City, OK 73104 |
| Phone Number: | (405) 818-0967 |
| Contact Person: | Kris Vermelis |
| NAICS Code: | 541712 |
| SIC Code: | 8731 |
| Business Type: | B2B (Business to Business) |
| Employee #: | 1 to 4 |
| Location Type: | Single Location |
| Annual Revenue ($): | $100.000 to $499.999 |
| Share This Business: | |
| Similar Businesses: |
Sensiq Technologies Inc - Oklahoma City, OK 73104 Dormatarg Inc - Oklahoma City, OK 73104 Advancia Corporation - Oklahoma City, OK 73104 Siwa Biotech - Oklahoma City, OK 73104 Estuary Therapeutics Inc - Oklahoma City, OK 73104 Eyecro LLC - Oklahoma City, OK 73104 Techven Partners LLC - Oklahoma City, OK 73104 Aaron Wendelboe - Oklahoma City, OK 73104 OK Medical Research Foundation - Oklahoma City, OK 73104 |
Northbound Therapeutics Inc, a stable growing company under Research and Development Laboratories, is being run by Kris Vermelis. Since , their sales have been favorable and consistent at $100.000 to $499.999. Company location coordinates are: .
It can be reached by dialing (405) 818-0967, and you could get in touch with their sales team in 940 Sl Young Boulevard, Oklahoma City, Oklahoma OK 73104. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8731 and NAIC – 541712. Call the hotline stated above for faster transaction and queries. Northbound Therapeutics Inc would like to hear from you.